InvestorsHub Logo

Doctor Detroit

10/02/17 10:17 AM

#12322 RE: TRUISM #12321

Sherlock Holmes might make something of this...


From today's press release: "Additional ProNeura feasibility evaluations are ongoing in the area of chronic pain treatment with a peripherally acting Kappa opioid receptor agonist, and in the treatment of type 2 diabetes with currently approved peptides. "

From the "Pipeline" section of Cara Therapeutics website:

"Cara Therapeutics is developing the first peripherally acting kappa opioid receptor agonist (KORA) called CR845."

http://www.caratherapeutics.com/pipeline-technology/kappa-opioid-receptor-agonists/

Cheetah SPEED

10/27/17 6:11 PM

#12447 RE: TRUISM #12321

Looking good here